These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29412808)

  • 41. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
    de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of resistin in Behçet's disease: a Turkish experiment.
    Pehlivan Y; Onat AM; Okumuş S; Kisacik B; Comez G; Comez A; Goktepe F; Ceylan NO
    Mod Rheumatol; 2012 Aug; 22(4):571-5. PubMed ID: 22038316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease.
    Kato Y; Yamamoto T
    Int J Dermatol; 2012 Mar; 51(3):286-9. PubMed ID: 22348563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased protein S activity is related to the disease activity of Behcet's disease.
    Kwon SR; Lim MJ; Park SG; Moon YS; Park W
    Rheumatol Int; 2006 Nov; 27(1):39-43. PubMed ID: 16969634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin D Levels in Patients with Behcet's Disease: A Systematic Review and Meta-Analysis.
    Hashemzadeh K; Rezazadeh M; Eftekhari A; Esparham A; Jokar MH; Kheradmand HR
    Curr Rheumatol Rev; 2022; 18(3):203-211. PubMed ID: 35184713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis.
    Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F
    Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum oxidant/antioxidant status in patients with Behçet's disease.
    Taysi S; Kocer I; Memisogullari R; Kiziltunc A
    Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
    Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
    Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.
    Cantarini L; Pucino V; Vitale A; Talarico R; Lucherini OM; Magnotti F; De Rosa V; Galgani M; Alviggi C; Marone G; Galeazzi M; Matarese G
    Clin Exp Immunol; 2016 May; 184(2):197-207. PubMed ID: 26756979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease.
    Örem A; Yayli S; Arıca DA; Akcan B; Yücesan FB; Bahadir S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C; Er H; Türköz Y; Cekmen M
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease.
    Lee HJ; Kim JH; Kim SW; Joo HA; Lee HW; Kim YS; Park SJ; Hong SP; Kim TI; Kim WH; Kim YH; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):1953-1962. PubMed ID: 28523576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of the correlation of serum selenium level with Behcet's disease.
    Esalatmanesh K; Jamshidi A; Shahram F; Davatchi F; Masoud SA; Soleimani Z; Salesi M; Ghaffarpasand I
    Int J Rheum Dis; 2011 Oct; 14(4):375-8. PubMed ID: 22004235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum-soluble selectin levels in patients with Behçet's disease.
    Ateş A; Tiryaki OA; Olmez U; Tutkak H
    Clin Rheumatol; 2007 Mar; 26(3):411-7. PubMed ID: 17206396
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Behçet's disease.
    Mumcu G; Inanc N; Aydin SZ; Ergun T; Direskeneli H
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S32-6. PubMed ID: 19796530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
    Erturan I; Basak PY; Ozturk O; Ceyhan AM; Akkaya VB
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1414-8. PubMed ID: 19522774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitamin D status in Algerian Behçet's disease patients: an immunomodulatory effect on NO pathway.
    Djeraba Z; Benlabidi F; Djaballah-Ider FZ; Medjeber O; Arroul-Lammali A; Belguendouz H; Otmani F; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):243-250. PubMed ID: 28532201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.